Introduction: Talking about death and dying is evoking discomfort in many persons, resulting in avoidance of this topic. However, end-of-life discussions can alleviate distress and uncertainties in both old and young adults, but only a minority uses this option in palliative care. Even in healthy populations, talking about death is often seen as alleviative and worthwhile, but rarely initiated. Objective: To investigate different psychological interventions (a) encouraging the readiness for end-of-life discussions and (b) changing death attitudes in healthy adults of different ages. Methods: 168 participants were randomized to four different interventions (IG1: value-based intervention with end-of-life perspective, IG2: motivation-based intervention with end-of-life perspective, IG3: combination of IG1 and IG2, CG: control group). Primary outcome was the readiness to engage in end-of-life topics. Secondary outcomes were fear of death, fear of dying and death acceptance. Assessments took place before, directly after the intervention and at 2 weeks of follow up. Results: IG2 and IG3 reported significantly more changes in the readiness to engage in end-of-life discussions than the CG (F[5.61, 307] = 4.83, p < 0.001, ηp2 = 0.081) directly after the intervention. The effect of IG3 remained stable at the follow-up. There were no significant effects of the interventions on end-of-life fears or death acceptance. Acceptability of the interventions was very high. Conclusions: Short interventions can be useful to encourage end-of-life discussions and could be integrated in health care programs. The efficacy and effectiveness of these short interventions in palliative patients are currently examined.

In Germany, the annual death rate will increase in the future because of an aging population [1]. Even though the majority of deaths are accounted for by older people, young adults can also be affected for example due to an unfavorable course of a cancer disease [2]. It is generally accepted as an existential feature given that all human beings have to die one day, and there appear to be global and cross-cultural similarities on what is important at the end of life [3-5]. This includes the possibility to be with loved ones, to die with dignity, to be self-determined, to be free of pain, and not to be a burden. Moreover, most persons wish to die at home and not in hospitals [6, 7].

To enable patients’ end-of-life preferences within personalized care and ensure high congruence between the wishes and reality, open conversations about death, dying and care are of high importance. End-of-life discussions are associated with less aggressive medical treatment close to death, and therefore with better quality of life [8, 9]. Moreover, end-of-life communication is related to lower health care costs and reduced caregiver burden [10, 11]. Caregivers’ bereavement adjustment and quality of life were better when end-of-life discussions took place [8, 12]. One possibility to realize a structured discussion about relevant end-of-life topics is including patients’ values in advance care planning [13]. Advance care planning can alleviate uncertainties and is associated with higher satisfaction with palliative care in both old and young adults [12, 14, 15].

Despite these advantages, end-of-life communication is challenging due to numerous barriers such as lacking knowledge [16, 17]. Important psychological aspects in end-of-life communication are the attitudes and emotions regarding death as death anxiety. Research about death attitudes and death anxiety spans from the 50s over the 70s until now [18, 19]. In times of COVID-19 these topics appear especially relevant [20]. The psychosomatic syndrome of death anxiety – thanatophobia (Diagnostic Criteria for Psychosomatic Research) includes the fear of death and avoidance of news that remind of death [21]. Moreover, death anxiety can be seen as a transdiagnostic construct and a possible core fear in mental disorders such as hypochondria, panic disorder and depressive disorders [22]. Thus, death anxiety was shown to be a strong predictor of various aspects of psychopathology [23]. In an oncological sample 8.2% of the patients showed the syndrome of thanatophobia [24], but it is also present in healthy populations [18, 25]. Thanatophobia or death anxiety can be a relevant factor to avoid end-of-life topics, whereas death acceptance is associated with a higher degree of awareness and abilities to reflect on death and dying [26, 27]. Thus, attitudes toward death are relevant determinants to address in this context.

The ambivalence seems to be strong: although many persons perceive end-of-life discussions and advance care plans as important, rates of uptake are relatively low in cancer patients and in the general population [16, 28]. Research showed that patients prefer to speak very late about end-of-life topics [29] which can sometimes be too late. There are different steps necessary to complete an advance care plan or an end-of-life discussion which can be identified with the transtheoretical model of behavior change [30]. Fried et al. [30] argue that individualized interventions targeted at individual stages of behavior change for different components of end-of-life discussions may be useful. If persons do not feel ready to talk about end-of-life issues, it can cause harm to engage them in such discussions [31]. Thus, it might be relevant to first address the readiness and clarify personal values before starting an end-of-life conversation. The ambivalence should be addressed by motivation-focused approaches [32].

Typical attitudes of the general population are characterized by a paradox: most people want to die in an environment that is informed about their preferences for the final period of life [16]. However, emotional, cognitive, communicative, relational and external processes can hinder end-of-life communication within the family [33]. A recent review showed that the most frequently reported barriers were emotional and cognitive processes such as protective buffering or belief in positive thinking [33]. Thus, relatives attempt to protect their loved ones from emotional upset and psychological burden(e.g., “I don’t want to cause any sadness”), wish to maintain hope and optimism (e.g., discussing death makes it a reality) or believe that they already know the preferences of the other [34]. Moreover, they attempt to be able to continue their family roles and relationships (e.g., to maintain their hierarchical role and identity as the parent or the strong partner and not as weak) [35]. Considering that end–of-life discussions can be a valuable, intense and existential experience, the avoidance of these discussions is questionable even in healthy people. Despite the universality of dying, scientifically based knowledge and experience of how to lead these discussions in the general population are low.

There already exist some end-of-life communication interventions targeting patients, health care professionals or other stakeholders [36], but no study explicitly focuses on the individual readiness. Furthermore, a review showed that research is widely lacking in encouraging healthy persons in end-of-life discussions [37]. Only a few empirical studies exist that evaluate interventions targeting healthy populations, and no study had a controlled design. The review pointed out that it is essential to actively engage people rather than passively providing information and to ensure a proper setting for interventions. Nevertheless, data are limited, and there is a need for more research about beneficial and feasible interventions [37]. Moreover, interventions that address end-of-life attitudes and death anxiety in several populations (general population as well as patients with advanced cancer) were shown to be effective, but there exist a large heteronomy of study quality [38, 39] and the need for randomized controlled trials (RCTs). Thus, the research question of this experimental (randomized) study was whether different microinterventions (including an existential focus on values and motivation) can (a) increase the readiness to engage in end-of-life topics and (b) increase death acceptance and decrease end-of-life fears. Additionally, this study evaluates the effect of different age ranges on the mentioned variables.

Study Design

Accompanying a large RCT with palliative cancer patients (registered under ClinicalTrials.gov, NCT03387436), this trial used an experimental design and aimed to analyze two different microinterventions and the combination of those in a healthy sample. Results are compared to a control group receiving a neutral intervention. Ethical approval was obtained from the respective local ethics committees (ref. No. 2018-5k-2). In the aforementioned RCT with palliative cancer patients (Hand-in-Hand Study), the combination approach will be evaluated and compared to treatment as usual and a control intervention. Thus, the aim of this experimental study was to gain further insights into the two different component parts of the psychological intervention (dismantling design).

Data were collected between April 2018 and July 2018. To enable subanalyses about age differences, participants from two different stages in life, e.g. a younger (aged 18–35 years) and an older (aged 65–88 years) sample were included. Participants were recruited through study announcements in public places such as libraries, family doctor practices, adult education centers, retirement homes, university classes and rehabilitation sport. As an incentive, participants could take part in a prize draw for vouchers redeemable with a local voucher card. Persons had to be able to give informed consent and to have sufficient German language skills. Exclusion criteria were the presence of any life-threatening illness and severe mental illness (e.g., psychosis, suicidality). After providing written informed consent, all patients received a structured information about death statistics in Germany, in order to homogenize knowledge and salience of death. Then, participants filled in the baseline questionnaire (online via Uniparc or paper-pencil) and were randomly assigned to receive the value-based intervention (IG1), the motivation-focused intervention (IG2), the combination of IG1 and IG2 (IG3) or the control intervention (CG). The allocation sequence was computer-generated in blocks of 20 persons by an independent researcher of the working group. The intervention took place personally 1 week after the baseline questionnaire (preintervention assessment) at the psychological institute of Marburg. Immediately after the intervention, the participants completed the second questionnaire (postintervention assessment). Two weeks after the intervention the participants got the follow-up questionnaire online via a link in an e-mail or by paper-pencil on the postal way with an addressed return envelope. Assessment took place under blind conditions. Moreover, participants were blinded after assignment to the intervention. After the follow-up assessment, they received clarifications about the study aims and their intervention group.

Psychological Microinterventions

Participants received one individual microintervention of 40–50 min (combination group 60–75 min) duration by a master student of clinical psychology. All master students received intensive training and supervision by experienced clinical psychologists. All sessions were audiotaped to control for therapeutic allegiance and to ensure high quality of the supervision process.

Value-Based Intervention with an End-of-Life Perspective

The value-based intervention was designed on the basis of dignity therapy [40, 41] which is a psychological intervention in palliative care. Participants were asked the questions of the Dignity Therapy Question Protocol, e.g. “Tell me a little about your life history; particularly the parts that you either remember most or think are the most important” or “Are there particular things that you feel still need to be said or things that you want to take the time to say once again?” An overview over the whole protocol is provided in the online supplementary Appendix B (for all online suppl. material, see www.karger.com/doi/10.1159000511199). The most important sentences were written or drawn on a record card that the participant could take along. The aim of the value-based intervention was to clarify the person’s individual values in life as one of the first steps in end-of-life conversations or/and an advance care planning process [42].

Motivation-Focused Intervention with an End-of-Life Perspective

This motivation-focused intervention was designed on the basis of motivational interviewing [32] which is a psychological style to enhance readiness for change by taking into account people’s ambivalence. Participants were asked about the barriers and the advantages of engaging in end-of-life topics and starting end-of-life discussions, e.g. “What difficulties could come along for you if you speak about the end of life, death and dying with your loved ones?”, “Which benefits could such talks have?”or “What would be important topics to speak about in regard of your own end of life?” The most important sentences were written on a record card that the participant could take along. The aim of the motivation-focused intervention was to improve people’s readiness to engage in end-of-life topics as the possible first step in end-of-life conversations or/and an advance care planning process.

Combined Intervention

The combined intervention was a combination of the value-based and the motivation-focused intervention.

Control Intervention

The control intervention was designed as a discussion about general health topics like healthy nutrition, workout, alcohol consumption and donating blood. Participants were asked about their own rules for a healthy life, e.g. “How many minutes do you work out in the week?” or “How important is it for the society that persons donate blood?”The aim of the control group was to discuss health-related topics in life in the same amount of time as in the intervention groups, but not with a direct focus on end-of-life topics.

Assessment

Readiness to Engage in End-of-Life Topics

Readiness to engage in end-of-life topics was measured with 13 items (e.g. “Thinking about the end of life is part of life” or “For me it makes sense to talk about death and the dying process with my family/friends”). For the validation and psychometric evaluation of the Readiness for End-of-Life Conversations scale, see Berlin et al. [43]. The items were rated on a 6-point Likert scale from 0 “do not agree at all” to 5 “fully agree” (online suppl. Appendix A). A higher sum score indicates a higher readiness to engage in end-of-life topics. Internal consistency of the scale was high (Cronbach’s α = 0.86).

Moreover, patients were asked if they have an advance directive (“yes” or “no”) and in which individual stage of change after the transtheoretical model (precontemplation, contemplation, preparation, action, maintenance) they are in regard of fulfilling an advance directive according to Fried et al. [30].

End-of-Life Fears and Death Acceptance

The Multidimensional Orientation toward Dying and Death Inventory assesses attitudes about death in 8 subscales [44]. Due to economical reasons, in this study only the 3 subscales Fear of one’s own death with 6 items (“Thinking beyond the threshold of my death makes me afraid”), Fear of one’s own dying process with 8 items (e.g. “I am afraid of dying a painful death one day”) and Acceptance of dying and death with 8 items (e.g. “Basically, I am ready to accept that I have to die one day”) were applied. The items are scored in a 4-point Likert scale ranging from 0 to 3 (0 = agree not at all; 3 = agree almost totally). Higher sum scores indicate more fear or a larger acceptance, depending on the scale. Cronbach’s α for the subscales ranged from 0.82 to 0.92.

Depressive Symptoms and Sociodemographic Variables

Depressive symptoms were measured with the Patient Health QuestionnairePHQ-9 [45]. The questionnaire assesses depressive symptoms with 9 items. The items are scored in a 4-point Likert scale ranging from 0 to 3 (0 = not at all; 3 = nearly every day). Higher sum scores indicate more depressive symptoms (Cronbach’s α = 0.89).

Age, education, gender, nationality, marital status, religiosity (“yes” or “no”) and chronic disease (“yes” or “no”) were assessed within the baseline questionnaire. Moreover, participants were asked “if they have ever been faced with death, e.g. through illness or an accident”(“yes” or “no”), and “if they have experienced the death of a close person” (“yes” or “no”).

Participants’ Evaluation of the Intervention

Participants evaluated the intervention on three statements rated on a 6-point Likert scale from 1 “do not agree at all” to 6 “fully agree” as part of the postintervention questionnaire (“the intervention was helpful,” “I felt comfortable during the intervention” and “The content of the intervention was displeasing to me”).

Data Analysis

According to the results of a power analysis calculated with g*power, a minimum of 116 participants was required in order to achieve a small effect in a mixed-design analysis of variance (ANOVA) with 80% power and a significance level of 0.05. We expected a small effect on the basis of prior research [39]. First, a data screening was conducted, testing the assumptions of multivariate analyses of variance (MANOVA) and mixed ANOVAs. In cases of a violation of the sphericity, the Greenhouse-Geiser correction was used. For a dropout analysis, a MANOVA was conducted to analyze possible baseline differences between dropouts and study completers. Next, another MANOVA was performed to examine possible baseline differences between the four different intervention groups. Subsequently, a mixed 4 × 3 ANOVA with the within-subject factor “time” and the between-subject factor “group” for the dependent variable readiness was conducted. Bonferroni-corrected post hoc tests were performed to control for problems of multiple testing (α-error accumulation). Analyses of covariance were performed to control for age, gender, education, chronic illness, death of a close person and prior contact with death. Further MANOVAs were conducted to analyze changes in end-of-life fears and death acceptance and investigate effects of different age groups. All statistical analyses were performed using SPSS Statistics 24 for Windows.

Participant Flow

Out of 269 participants who started to fill in the baseline assessment, 221 finished the assessment. 28 participants declined participation, and 9 baseline questionnaires were not coded correctly and could not be assigned. Thus, 184 persons were randomized to IG1 (n = 47), IG2 (n = 42), IG3 (n = 48) and CG (n = 47). Of those, 168 completed all assessments with a valid code (91.3%) (Fig. 1). Dropout analyses were conducted between the persons who further participated in the study (n = 168) and those who did not (n = 28). In a MANOVA the dropouts had higher reported values in the variables “fear of death” (F[1, 191] = 21.90, p< 0.001, ηp² = 0.10), “fear of dying” (F[1, 191] = 10.45, p = 0.001, ηp² = 0.05) and lower values in “death acceptance”(F[1, 191] = 11.00, p = 0.001, ηp² = 0.05). No significant differences appeared in the variable “readiness to engage in end-of-life topics” (F[1, 191] = 2.41, p = 0.122, ηp² = 0.01).

Fig. 1.

Trial profile.

Baseline Characteristics

All baseline sociodemographic characteristics are shown in Table 1. There were no significant differences between the groups.

Table 1.

Demographic characteristics at baseline of the individuals

Demographic characteristics at baseline of the individuals
Demographic characteristics at baseline of the individuals

Participants´ Evaluation of the Microintervention

All interventions were equally evaluated as very positive. There were no significant differences between the groups. 94.4% of all participants found the interventions rather helpful to very helpful in the IGs and 90.9% in the CG. Most participants felt rather comfortable to very comfortable with the interventions (98.4%) in the IGs and in the CG (97.7%). Nobody from the CG, 3 persons from IG1, 4 persons from IG2 and 1 person from IG3 evaluated the contents of the interventions as rather challenging to very challenging. The challenging rating was negative correlated with baseline readiness (r = –0.147, p = 0.028) and positive correlated with baseline fear of death (r = 0.185, p = 0.020) indicating that persons who had lower scores in the readiness and higher scores in fear of death rated the interventions as more burdening. Moreover, there was a significant correlation if a person had faced death (r = –0.220, p = 0.007). There were no significant correlations between the challenging rating and fear of dying (r = 0.018, p = 0.016), death acceptance (r = –0.111, p = 0.076), depression (r = 0.041, p = 0.326), age (r = –0.066, p = 0.234), gender (r = 0.013, p = 0.444) or religiosity (r = –0.060, p = 0.254).

Changes in Readiness to Engage in End-of-Life Topics

A mixed 4 × 3 ANOVA (with Greenhouse-Geisser correction) with the within-subject factor “time” and the between-subject factor “group” revealed for the dependent variable readiness a significant effect of “time”(F[1.87, 306.9] = 72.90, p<0.001, ηp² = 0.31) and a significant “time × group interaction” (F[5.61, 306.9] = 4.83, p< 0.001, ηp² = 0.081), whereas no main “group” effect was found (F[3, 164] = 1.49, p = 0.220, ηp² = 0.026). The significant interaction effect indicated different effects on readiness between the study groups. Mean values and SD for the analyses are summarized in Table 2. The results remained stable after controlling for possible confounders such as age, gender, education, chronic illness, death of a close person and being faced with death. Analyzing the differences in estimated mean scores of the readiness before and after the intervention, Bonferroni-corrected post hoc tests revealed that IG2 (mean difference, Mdiff = –4.03, standard error, SE = 1.38, p = 0.025, d = 0.60) and IG3 (Mdiff = –6.05, SE = 1.37, p < 0.001, d = 0.88) but not IG1 (Mdiff = –3.14, SE = 1.35, p = 0.126) had greater changes in the readiness than the CG. These results indicated that the motivation-focused group and the combination group had more changes in their readiness to engage in end-of-life conversations after the intervention than the CG. Moreover, Bonferroni-corrected post hoc tests showed that IG3 (Mdiff = –4.85, SE = 1.31, p = 0.002, d = 0.78) but not IG1 (Mdiff = –1.09, SE = 1.28, p = 1.0) and IG2 (Mdiff = –2.82, SE = 1.33, p = 0.211) had greater changes in the readiness from baseline to the follow-up than the CG. IG1 showed smaller changes than IG3 from baseline to follow-up (Mdiff = –3.90, SE = 1.33, p = 0.024, d = 0.64) (Fig. 2). These results indicated that the readiness significantly increased in the combination group from baseline to 2 weeks after the intervention compared to the CG and the value-based group. Additionally, the respective readiness score over all groups was associated with the transtheoretical model behavior stage after the intervention (η2 = 0.266) and at follow-up (η2 = 0.337) indicating that persons with higher readiness scores were more willing to complete a living will or already did so.

Table 2.

Outcome measures at baseline, directly after the intervention and 2 weeks following the intervention in participants in the value-based group (IG1), the motivation-focused group (IG2), the combination group (IG3) and the control group (CG)

Outcome measures at baseline, directly after the intervention and 2 weeks following the intervention in participants in the value-based group (IG1), the motivation-focused group (IG2), the combination group (IG3) and the control group (CG)
Outcome measures at baseline, directly after the intervention and 2 weeks following the intervention in participants in the value-based group (IG1), the motivation-focused group (IG2), the combination group (IG3) and the control group (CG)
Fig. 2.

Differences in the estimated mean scores before versus after the intervention (a) and before versus 2 weeks following the intervention (b) in the value-based group (IG1), in the motivation-focused group (IG2), in the combination group (IG3) and in the control group (CG); error bars: ±1 standard error. EOL, end of life.

Fig. 2.

Differences in the estimated mean scores before versus after the intervention (a) and before versus 2 weeks following the intervention (b) in the value-based group (IG1), in the motivation-focused group (IG2), in the combination group (IG3) and in the control group (CG); error bars: ±1 standard error. EOL, end of life.

Close modal

Changes in End-of-Life Attitudes

In a mixed 4 × 3 MANOVA with the within-subject factor “time” and the between-subject factor “group” with fear of death, fear of dying and death acceptance as dependent variables, a significant effect of time (V = 0.90, F[6, 159] = 2.65, p< 0.019, ηp2 = 0.09) was found. Subsequent contrasts showed a higher score of death acceptance from baseline to postintervention (F[1, 164] = 6.24, p = 0.014, ηp2 = 0.037) with a return to baseline level at follow-up (F[1, 164] = 1.84, p < 0.226, ηp2 = 0.009). Moreover, contrasts showed a significantly higher score of fear of dying from baseline to postintervention with a return to baseline level at 2 weeks of follow-up (F[1, 164] = 0.95, p < 0.758, ηp2 = 0.001). There was no “time” effect on the reported fear of death (F[1, 160] = 0.66, p = 0.416, ηp2 = 0.004). Thus, persons of all groups reported higher death acceptance and higher fear of dying after the intervention but both values turned to baseline levels after 2 weeks. There was neither a main group effect (V = 0.94, F[9, 394] = 1.210, p = 0.287, ηp2 = 0.02) nor a significant “time × group interaction” effect (V = 0.94, F[18, 450] = 0.61, p = 0.897, ηp2 = 0.02). The results stayed stable after controlling for possible confounders such as age, gender, education, chronic illness, death of a close person and being faced with death.

Effects of Different Age Groups

To investigate the moderating influence of age we included the two different age groups (young adults vs. older adults) in a mixed 2 × 4 × 3 MANOVA with the between-subject factors “age group” and “intervention group” and the within-factor “time” for the dependent variables “readiness,” “death acceptance,” “fear of death” and “fear of dying” at the baseline measurement. There was no significant interaction of “age group” × “intervention group” × “time” (F[24, 465] = 0.83, p = 0.702, ηp2 = 0.041), indicating that age had no moderating role on the effect of the interventions. There was, however, a significant main effect of age group (F[4, 157] = 10.81, p < 0.001, ηp2 = 0.216). Subsequent univariate analyses showed a significant direct effect of age on the reported readiness (F[1, 160] = 15.04, p < 0.001, ηp2 = 0.086), death acceptance (F[1, 160] = 21.39, p < 0.001, ηp2 = 0.118), fear of death (F[1, 160] = 22.87, p < 0.001, ηp2 = 0.125) but not on the reported fear of dying (F[1, 160] = 0.66, p = 0.416, ηp2 = 0.004). Thus, persons in an older age range showed a higher readiness to talk about the end of life, reported a higher death acceptance and less fear of their own death, while older persons and young persons showed the same amount of fear of their own dying process.

The central aim of this experimental design study was to examine the effect of three microinterventions (value-based, motivation-focused, the combination of both) on the readiness for end-of-life discussions and end-of-life attitudes in healthy adults of different ages. The motivation-focused group and the combination group demonstrated higher readiness in end-of-life conversations after the intervention than the CG. This result was stable at the follow-up for the combination group. In contrast, no group effects on death attitudes such as fear of death, fear of dying and death acceptance were found.

The main finding, i.e. that the combination group had the highest effect on the readiness, is in line with prior studies, showing that involving values can facilitate the initiation of an end-of-life talk [42]. Including values and dignity-related questions might cause less distress and act as an icebreaker [46]. Nevertheless, to speak about values and dignity alone does not seem to be sufficient to attain a higher engagement in end-of-life themes. A motivation-focused approach that considers persons’ ambivalence seems to be helpful. A relevant approach can be the concept of “double awareness” which has been developed within the psychotherapy for patients living with advanced cancer and takes into account the impossibility of avoiding awareness of death while continuing to engage in life [47]. Encouraging double awareness means to promote the flexibility of mind between life awareness and death awareness and seems to be a very useful approach in this context. Another relevant part of the motivation-focused approach includes the provision of information, considering that lack of knowledge represents a relevant barrier in engaging in end-of-life discussions [48, 49]. While prior studies have used different strategies for older persons (e.g., peer education program on end-of-life planning) and younger persons (e.g., an arts project that brought together hospice users and school pupils) [37], in this study the same interventions seem to work for both, older and younger adults. Thus, the interventions seem to be flexible enough to consider the participants at their stages of readiness in the transtheoretical model of behavior change. Further research should evaluate these microinterventions in other settings, for example with patients with cancer in palliative settings. It would also be of interest whether the interventions could be adapted to an online version to enable easier utilization.

The finding that the interventions were widely evaluated as helpful underlines the feasibility of the interventions. It seems to be useful to start discussing one’s own end of life early in life, even when it is not acute [50, 51]. On one hand, persons engage more in end-of-life topics, when it is more relevant for them. On the other hand, the time proximate to acute dying is often experienced as highly demanding and tense for dying persons and their families. Of note, also young people considered the discussions as valuable and helpful, e.g. to live their own lives more consciously and meaningfully [52]. Conversations earlier in life may facilitate preparations for substitute decision-making on a critically ill person’s behalf. Previous research pointed out a gap between perceived and actual preparedness to be a substitute decision-maker for a loved one with a critical illness. In one study, 73% of 404 Canadian persons felt prepared to be a substitute decision-maker, although 45.1% reported never having had meaningful conversations with loved ones to understand their wishes in the event of critical illness [53]. Thus, announcing advance care planning earlier in adulthood (e.g., beginning with healthy adults) might be helpful to warrant that the process of advance care planning includes continuing contemplation and conversations of goals of care. Preferably, advance care planning is nothing that is ever completed, but a process that should be addressed and re-addressed across the adult lifespan [54]. It could be helpful to speak about these topics early in life to build on these discussions in critical times when persons become seriously ill.

Nevertheless, 8 persons (both young and older adults) evaluated the contents of the interventions as rather challenging to very challenging. This finding shows that even in persons who are not affected by the threat of a prompt death (like palliative cancer patients), end-of-life-related topics are difficult to speak about. Because death anxiety was associated with higher burden through the intervention and with higher dropout rates after the baseline measurement, the syndrome of thanatophobia including the wish to avoid death-related topics has to be taken into account [21]. Other psychological constructs that appear to be relevant are neuroticism, less sense of coherence or less mindfulness [55]. Interestingly, also persons who faced death in other contexts rated the intervention as more challenging. All these points have to be considered when addressing these topics to more affected persons.

Persons of an older age showed a higher readiness to talk about the end of life, reported a higher death acceptance and less fear of their own death than young persons, which is in line with prior research [56]. Although death and dying become more salient with higher age, the fear of death often decreases. Interestingly, the fear of dying was the same in the older and the younger sample. The results are partly consistent with a representative German study that found a higher approval of older persons in the item “People are more afraid of the process of dying than they are of death” than in the younger sample [57]. A possible explanation for our results could be that fear of dying has more practical and specific components, for example the fear to suffer from pain or to die alone, which can be more salient in old but also in young adults. Network analyses about different death-related fears showed that fears were organized into two areas: one of more practical fears concerning the process of dying, and another of more psychosocial or existential concerns, for example missed opportunities [58]. Thus, a majority of older persons might find their ways to handle existential threat for example through religiosity but need support with their fears of the dying process while younger people feel more of an existential threat.

Our study could not find a group effect on fear of death, fear of dying and death acceptance. This finding is contrary to prior research, showing small to medium effects, especially of cognitive behavioral interventions [39]. A possible explanation is that our microintervention consisted only of one session of about 50 min. Moreover, master students of clinical psychology and no advanced therapists conducted the interventions. It might need more time and more training to change such profound fears [22]. A longer intervention over a longer time period might be necessary to positively influence death anxiety (thanatophobia). Thus, a recent meta-analysis of interventions of death anxiety found a higher number of sessions associated with a greater reduction of death anxiety (the mean number of sessions that produced significant changes was 7.92) [39]. Interestingly, scores of death acceptance and fear of dying had both a small increase from baseline to postintervention in all groups and returned to baseline level after 2 weeks. This effect might emerge due to the repeated assessments including questions about death and dying. The finding that both – death acceptance and fear of dying – increased fits well in the concept of double awareness [47]. On one hand, persons might become aware that life is limited, but on the other hand accept this fact as something valuable.

As clinical implication, the integration of short interventions encouraging end-of-life conversations can be valuable and helpful in general health care even in healthy persons but maybe also in clinical populations. Speaking about end-of-life topics might be alleviating and value-increasing, the concept of double awareness seems to be helpful. Nevertheless, end-of-life encouraging interventions have to be held with sensitiveness, especially in persons with higher death anxiety and persons who have faced death in their lives.

Strengths and Limitations

One of the strengths of the study, among others, is that although research about death anxiety and death communication has been around for decades, robustly designed RCT studies in this area are rare. To our knowledge, there exist more observational studies and fewer experimental studies comparing different end-of-life encouraging interventions. Moreover, our study included a relatively broad sample allowing comparisons between younger and older adults.

Following the methodological recommendations for trials of psychological interventions [59], some methodical limitations have to be considered in this study. The maladaptive illness behavior of thanatophobia was not checked as described by the diagnostic criteria for psychosomatic research [21, 60]. Medication intake was not assessed, and no observer-rated tools were used; the study only focused on patient-reported outcomes. Thus, it would have been interesting to assess on a behavioral level, whether persons will have conducted end-of-life discussions and advance care planning in the months following the intervention. Moreover, the primary outcome was revealed from a self-constructed questionnaire, which is validated by our research group. The survey might also have acted as an intervention itself, prompting more thoughts on preparation for the end of life in the CG. The finding that death acceptance and fear of dying increased over all groups (even in the CG) and decreased after 2 weeks might be explained by this point. Another important limitation was that the study sample was selective, as dropout analyses indicated that persons with higher fear of death and dying and less death acceptance were more at risk not to proceed in the study. Obviously, it would be interesting to especially include persons that avoid speaking about these topics and might benefit from such interventions to a higher extent. Nonetheless, the denial of death topics is a strategy, which can be appropriate in some phases of life and therefore must be accepted by investigators. Additionally, the follow-up in this study was only 2 weeks. In interventions that have long-term aims as the readiness to engage in end-of-life topics, longer follow-up terms would be preferable in forthcoming studies.

Short interventions can be useful to encourage the readiness to engage in end-of-life discussions also in healthy persons and could facilitate end-of-life discussions and advance care planning. The combination of value-based and motivation-focused aspects seem to be helpful. After participation, the evaluation of acceptability of these conversations was very high. Further research is needed to investigate these interventions with palliative samples (e.g., advanced cancer patients).

We thank Luisa Welsch, Charlotte Barth, Johannes Hauck, Sinja Kemper, Ingmar Connell, Franziska Schreiber and Nadja Angersbach for data collection.

The study was conducted ethically in accordance with the Declaration of Helsinki. All participants have given their written informed consent, and the study protocol was approved by the respective local ethics committees (ref. No. 2018-5k-2).

The authors have no conflicts of interest to declare.

The study was accompanying research to an ongoing large RCT funded by the German Federal Ministry of research and education to PD Dr. Carola Seifart. Funding-ID: 01GY1708. This funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data or decision to submit results.

P.B., N.L., K.N. and W.R. contributed to the design of the study. P.B., N.L. and K.N. administered the project. P.B. and K.N. performed the statistical analyses. P.B. drafted the manuscript. C.S. was responsible for the funding acquisition. All authors contributed to the interpretation of the data and offered critical revisions of the draft. All authors read and approved the final paper.

1.
Scholten
N
,
Günther
AL
,
Pfaff
H
,
Karbach
U
.
The size of the population potentially in need of palliative care in Germany—an estimation based on death registration data
.
BMC Palliat Care
.
2016
Mar
;
15
(
1
):
29
.
[PubMed]
1472-684X
2.
Gondos
A
,
Hiripi
E
,
Holleczek
B
,
Luttmann
S
,
Eberle
A
,
Brenner
H
;
GEKID Cancer Survival Working Group
.
Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison
.
Int J Cancer
.
2013
Nov
;
133
(
9
):
2207
15
.
[PubMed]
0020-7136
3.
Cox
K
,
Bird
L
,
Arthur
A
,
Kennedy
S
,
Pollock
K
,
Kumar
A
, et al
Public attitudes to death and dying in the UK: a review of published literature
.
BMJ Support Palliat Care
.
2013
Mar
;
3
(
1
):
37
45
.
[PubMed]
2045-435X
4.
Steinhauser
KE
,
Christakis
NA
,
Clipp
EC
,
McNeilly
M
,
Grambow
S
,
Parker
J
, et al
Preparing for the end of life: preferences of patients, families, physicians, and other care providers
.
J Pain Symptom Manage
.
2001
Sep
;
22
(
3
):
727
37
.
[PubMed]
0885-3924
5.
Rietjens
JA
,
van der Heide
A
,
Onwuteaka-Philipsen
BD
,
van der Maas
PJ
,
van der Wal
G
.
Preferences of the Dutch general public for a good death and associations with attitudes towards end-of-life decision-making
.
Palliat Med
.
2006
Oct
;
20
(
7
):
685
92
.
[PubMed]
0269-2163
6.
Gomes
B
,
Higginson
IJ
,
Calanzani
N
,
Cohen
J
,
Deliens
L
,
Daveson
BA
, et al;
PRISMA
.
Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain
.
Ann Oncol
.
2012
Aug
;
23
(
8
):
2006
15
.
[PubMed]
0923-7534
7.
Waller
A
,
Sanson-Fisher
R
,
Zdenkowski
N
,
Douglas
C
,
Hall
A
,
Walsh
J
.
The Right Place at the Right Time: Medical Oncology Outpatients’ Perceptions of Location of End-of-Life Care
.
J Natl Compr Canc Netw
.
2018
Jan
;
16
(
1
):
35
41
.
[PubMed]
1540-1405
8.
Wright
AA
,
Zhang
B
,
Ray
A
,
Mack
JW
,
Trice
E
,
Balboni
T
, et al
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment
.
JAMA
.
2008
Oct
;
300
(
14
):
1665
73
.
[PubMed]
0098-7484
9.
Starr
LT
,
Ulrich
CM
,
Corey
KL
,
Meghani
SH
.
Associations Among End-of-Life Discussions, Health-Care Utilization, and Costs in Persons With Advanced Cancer: A Systematic Review
.
Am J Hosp Palliat Care
.
2019
Oct
;
36
(
10
):
913
26
.
[PubMed]
1049-9091
10.
Fried
TR
,
Bradley
EH
,
O’Leary
JR
,
Byers
AL
.
Unmet desire for caregiver-patient communication and increased caregiver burden
.
J Am Geriatr Soc
.
2005
Jan
;
53
(
1
):
59
65
.
[PubMed]
0002-8614
11.
Zhang
B
,
Wright
AA
,
Huskamp
HA
,
Nilsson
ME
,
Maciejewski
ML
,
Earle
CC
, et al
Health care costs in the last week of life: associations with end-of-life conversations
.
Arch Intern Med
.
2009
Mar
;
169
(
5
):
480
8
.
[PubMed]
0003-9926
12.
Detering
KM
,
Hancock
AD
,
Reade
MC
,
Silvester
W
.
The impact of advance care planning on end of life care in elderly patients: randomised controlled trial
.
BMJ
.
2010
Mar
;
340
mar23 1
:
c1345
.
[PubMed]
0959-8138
13.
Rietjens
JA
,
Sudore
RL
,
Connolly
M
,
van Delden
JJ
,
Drickamer
MA
,
Droger
M
, et al;
European Association for Palliative Care
.
Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care
.
Lancet Oncol
.
2017
Sep
;
18
(
9
):
e543
51
.
[PubMed]
1470-2045
14.
Wiener
L
,
Zadeh
S
,
Battles
H
,
Baird
K
,
Ballard
E
,
Osherow
J
, et al
Allowing adolescents and young adults to plan their end-of-life care
.
Pediatrics
.
2012
Nov
;
130
(
5
):
897
905
.
[PubMed]
0031-4005
15.
Brinkman-Stoppelenburg
A
,
Rietjens
JA
,
van der Heide
A
.
The effects of advance care planning on end-of-life care: a systematic review
.
Palliat Med
.
2014
Sep
;
28
(
8
):
1000
25
.
[PubMed]
0269-2163
16.
Banner
D
,
Freeman
S
,
Kandola
DK
,
Meikle
M
,
Russell
BK
,
Sommerfeld
EA
, et al
Community perspectives of end-of-life preparedness
.
Death Stud
.
2019
;
43
(
4
):
211
23
.
[PubMed]
0748-1187
17.
Lund
S
,
Richardson
A
,
May
C
.
Barriers to advance care planning at the end of life: an explanatory systematic review of implementation studies
.
PLoS One
.
2015
Feb
;
10
(
2
):
e0116629
.
[PubMed]
1932-6203
18.
Neimeyer
RA
,
Wittkowski
J
,
Moser
RP
.
Psychological research on death attitudes: an overview and evaluation
.
Death Stud
.
2004
May
;
28
(
4
):
309
40
.
[PubMed]
0748-1187
19.
Tomer
A
.
Death anxiety in adult life—theoretical perspectives
.
Death Stud
.
1992
;
16
(
6
):
475
506
. 0748-1187
20.
Menzies
RE
,
Menzies
RG
.
Death anxiety in the time of COVID-19: theoretical explanations and clinical implications
.
Cogn Behav Therap
.
2020
;
13
:
e19
. Available from: https://www.cambridge.org/core/article/death-anxiety-in-the-time-of-covid19-theoretical-explanations-and-clinical-implications/3519FCFC320DA8821DD2E0EEB0B1EA5F1754-470X
21.
Fava
GA
,
Cosci
F
,
Sonino
N
.
Current Psychosomatic Practice
.
Psychother Psychosom
.
2017
;
86
(
1
):
13
30
.
[PubMed]
0033-3190
22.
Iverach
L
,
Menzies
RG
,
Menzies
RE
.
Death anxiety and its role in psychopathology: reviewing the status of a transdiagnostic construct
.
Clin Psychol Rev
.
2014
Nov
;
34
(
7
):
580
93
.
[PubMed]
0272-7358
23.
Menzies
RE
,
Sharpe
L
,
Dar-Nimrod
I
.
The relationship between death anxiety and severity of mental illnesses
.
Br J Clin Psychol
.
2019
Nov
;
58
(
4
):
452
67
.
[PubMed]
0144-6657
24.
Grassi
L
,
Sabato
S
,
Rossi
E
,
Biancosino
B
,
Marmai
L
.
Use of the diagnostic criteria for psychosomatic research in oncology
.
Psychother Psychosom
.
2005
;
74
(
2
):
100
7
.
[PubMed]
0033-3190
25.
Sinoff
G
.
Thanatophobia (Death Anxiety) in the Elderly: The Problem of the Child’s Inability to Assess Their Own Parent’s Death Anxiety State
.
Front Med (Lausanne)
.
2017
Feb
;
4
:
11
. Available from: https://www.frontiersin.org/article/10.3389/fmed.2017.00011
[PubMed]
2296-858X
26.
McGrath
P
.
Affirming the connection: comparative findings on communication issues from hospice patients and hematology survivors
.
Death Stud
.
2004
Nov
;
28
(
9
):
829
48
.
[PubMed]
0748-1187
27.
Tong
E
,
Deckert
A
,
Gani
N
,
Nissim
R
,
Rydall
A
,
Hales
S
, et al
The meaning of self-reported death anxiety in advanced cancer
.
Palliat Med
.
2016
Sep
;
30
(
8
):
772
9
.
[PubMed]
0269-2163
28.
Jimenez
G
,
Tan
WS
,
Virk
AK
,
Low
CK
,
Car
J
,
Ho
AH
.
Overview of Systematic Reviews of Advance Care Planning: Summary of Evidence and Global Lessons
.
J Pain Symptom Manage
.
2018
Sep
;
56
(
3
):
436
459.e25
.
[PubMed]
0885-3924
29.
Seifart
C
,
Riera Knorrenschild
J
,
Hofmann
M
,
Nestoriuc
Y
,
Rief
W
,
von Blanckenburg
P
.
Let us talk about death: gender effects in cancer patients’ preferences for end-of-life discussions
.
Support Care Cancer
.
2020
Oct
;
28
(
10
):
4667
75
.
[PubMed]
0941-4355
30.
Fried
TR
,
Redding
CA
,
Robbins
ML
,
Paiva
A
,
O’Leary
JR
,
Iannone
L
.
Stages of change for the component behaviors of advance care planning
.
J Am Geriatr Soc
.
2010
Dec
;
58
(
12
):
2329
36
.
[PubMed]
0002-8614
31.
Barnes
K
,
Jones
L
,
Tookman
A
,
King
M
.
Acceptability of an advance care planning interview schedule: a focus group study
.
Palliat Med
.
2007
Jan
;
21
(
1
):
23
8
.
[PubMed]
0269-2163
32.
Hettema
J
,
Steele
J
,
Miller
WR
.
Motivational interviewing
.
Annu Rev Clin Psychol
.
2005
;
1
(
1
):
91
111
.
[PubMed]
1548-5943
33.
Nagelschmidt
K
,
Leppin
N
,
Seifart
C
,
Rief
W
,
von Blanckenburg
P
.
Family Communication Barriers at end-of-life: A systematic mixed methods review
.
BMJ Support Palliat Care
. accepted. 2045-435X
34.
Caughlin
JP
,
Mikucki-Enyart
SL
,
Middleton
AV
,
Stone
AM
,
Brown
LE
.
Being Open without Talking about It: A Rhetorical/Normative Approach to Understanding Topic Avoidance in Families after a Lung Cancer Diagnosis
.
Commun Monogr
.
2011
;
78
(
4
):
409
36
. 0363-7751
35.
Generous
MA
,
Keeley
M
.
Wished for and avoided conversations with terminally ill individuals during final conversations
.
Death Stud
.
2017
Mar
;
41
(
3
):
162
72
.
[PubMed]
0748-1187
36.
Walczak
A
,
Butow
PN
,
Bu
S
,
Clayton
JM
.
A systematic review of evidence for end-of-life communication interventions: who do they target, how are they structured and do they work?
Patient Educ Couns
.
2016
Jan
;
99
(
1
):
3
16
.
[PubMed]
0738-3991
37.
Abba
K
,
Byrne
P
,
Horton
S
,
Lloyd-Williams
M
.
Interventions to encourage discussion of end-of-life preferences between members of the general population and the people closest to them - a systematic literature review
.
BMC Palliat Care
.
2013
Nov
;
12
(
1
):
40
.
[PubMed]
1472-684X
38.
Grossman
CH
,
Brooker
J
,
Michael
N
,
Kissane
D
.
Death anxiety interventions in patients with advanced cancer: A systematic review
.
Palliat Med
.
2018
Jan
;
32
(
1
):
172
84
.
[PubMed]
0269-2163
39.
Menzies
RE
,
Zuccala
M
,
Sharpe
L
,
Dar-Nimrod
I
.
The effects of psychosocial interventions on death anxiety: A meta-analysis and systematic review of randomised controlled trials
.
J Anxiety Disord
.
2018
Oct
;
59
:
64
73
. Available from: http://www.sciencedirect.com/science/article/pii/S0887618518302512
[PubMed]
0887-6185
40.
Chochinov
HM
,
Hack
T
,
Hassard
T
,
Kristjanson
LJ
,
McClement
S
,
Harlos
M
.
Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life
.
J Clin Oncol
.
2005
Aug
;
23
(
24
):
5520
5
.
[PubMed]
0732-183X
41.
Mai
SS
,
Goebel
S
,
Jentschke
E
,
van Oorschot
B
,
Renner
KH
,
Weber
M
.
Feasibility, acceptability and adaption of dignity therapy: a mixed methods study achieving 360° feedback
.
BMC Palliat Care
.
2018
May
;
17
(
1
):
73
.
[PubMed]
1472-684X
42.
Sudore
RL
,
Fried
TR
.
Redefining the “planning” in advance care planning: preparing for end-of-life decision making
.
Ann Intern Med
.
2010
Aug
;
153
(
4
):
256
61
.
[PubMed]
0003-4819
43.
Berlin
P
,
Leppin
N
,
Nagelschmidt
K
,
Seifart
C
,
Rief
W
,
von Blanckenburg
P
.
Development and validation of the Readiness for End-of-Life Conversations (REOLC)
.
Scale
. in prep.
44.
Wittkowski
J
.
The construction of the multidimensional orientation toward dying and death inventory (MODDI-F)
.
Death Stud
.
2001
Sep
;
25
(
6
):
479
95
.
[PubMed]
0748-1187
45.
Kroenke
K
,
Spitzer
RL
,
Williams
JB
.
The PHQ-9: validity of a brief depression severity measure
.
J Gen Intern Med
.
2001
Sep
;
16
(
9
):
606
13
.
[PubMed]
0884-8734
46.
Martínez
M
,
Arantzamendi
M
,
Belar
A
,
Carrasco
JM
,
Carvajal
A
,
Rullán
M
, et al
‘Dignity therapy’, a promising intervention in palliative care: A comprehensive systematic literature review
.
Palliat Med
.
2017
Jun
;
31
(
6
):
492
509
.
[PubMed]
0269-2163
47.
Colosimo
K
,
Nissim
R
,
Pos
AE
,
Hales
S
,
Zimmermann
C
,
Rodin
G
.
“Double awareness” in psychotherapy for patients living with advanced cancer
.
J Psychother Integration
.
2018
;
28
(
2
):
125
40
. 1053-0479
48.
Simon
J
,
Porterfield
P
,
Bouchal
SR
,
Heyland
D
.
‘Not yet’ and ‘Just ask’: barriers and facilitators to advance care planning—a qualitative descriptive study of the perspectives of seriously ill, older patients and their families
.
BMJ Support Palliat Care
.
2015
Mar
;
5
(
1
):
54
62
.
[PubMed]
2045-435X
49.
Peterson
LJ
,
Dobbs
D
,
Meng
H
,
Gamaldo
A
,
O’Neil
K
,
Hyer
K
.
Sharing End-of-Life Care Preferences with Family Members: Who Has the Discussion and Who Does Not
.
J Palliat Med
.
2018
Apr
;
21
(
4
):
463
72
.
[PubMed]
1096-6218
50.
Wildfeuer
J
,
Schnell
MW
,
Schulz
C
.
Talking about dying and death: on new discursive constructions of a formerly postulated taboo
.
Discourse Soc
.
2015
;
26
(
3
):
366
90
. 0957-9265
51.
Schnell
MW
,
Schulz-Quach
C
. 30 Gedanken – Eine öffentliche Diskursreihe zum Thema Sterben und Tod. In:
Schnell
MW
,
Schulz-Quach
C
, editors
.
Basiswissen Palliativmedizin
.
Berlin, Heidelberg
:
Springer Berlin Heidelberg
;
2019
. pp.
303
6
.
52.
Schnell
MW
,
Schulz
C
,
Kuckartz
U
,
Dunger
C
.
Junge Menschen sprechen mit sterbenden Menschen: eine Typologie
.
Springer-Verlag
;
2016
.
53.
Wong
MK
,
Medor
MC
,
Labre
KY
,
Jiang
M
,
Frank
JR
,
Fischer
LM
, et al
Gaps in public preparedness to be a substitute decision-maker and the acceptability of high school education on resuscitation and end-of-life care: a mixed-methods study
.
CMAJ Open
.
2019
Sep
;
7
(
3
):
E573
81
.
[PubMed]
2291-0026
54.
Mroz
E
,
Bluck
S
,
Smith
K
.
Young adults’ perspectives on advance care planning: evaluating the Death over Dinner initiative
.
Death Stud
.
2020
Feb
;
•••
:
1
10
.
[PubMed]
0748-1187
55.
Grevenstein
D
,
Bluemke
M
:
Who's Afraid of Death and Terrorists?
Investigating Moderating Effects of Sense of Coherence, Mindfulness, Neuroticism, and Meaning in Life on Mortality Salience. Journal of Articles in Support of the Null Hypothesis
2016
;13.
56.
Philipp
R
,
Mehnert
A
,
Lo
C
,
Müller
V
,
Reck
M
,
Vehling
S
.
Characterizing death acceptance among patients with cancer
.
Psychooncology
.
2019
Apr
;
28
(
4
):
854
62
.
[PubMed]
1057-9249
57.
Strupp
J
,
Köneke
V
,
Rietz
C
,
Voltz
R
.
Perceptions of and Attitudes Toward Death, Dying, Grief, and the Finitude of Life-A Representative Survey Among the General Public in Germany
.
Omega (Westport)
.
2019
Oct
;
•••
:
30222819882220
.
[PubMed]
0030-2228
58.
Vehling
S
,
Malfitano
C
,
Shnall
J
,
Watt
S
,
Panday
T
,
Chiu
A
, et al
A concept map of death-related anxieties in patients with advanced cancer
.
BMJ Support Palliat Care
.
2017
Dec
;
7
(
4
):
427
34
.
[PubMed]
2045-435X
59.
Guidi
J
,
Brakemeier
EL
,
Bockting
CL
,
Cosci
F
,
Cuijpers
P
,
Jarrett
RB
, et al
Methodological Recommendations for Trials of Psychological Interventions
.
Psychother Psychosom
.
2018
;
87
(
5
):
276
84
.
[PubMed]
0033-3190
60.
Porcelli
P
,
Guidi
J
.
The Clinical Utility of the Diagnostic Criteria for Psychosomatic Research: A Review of Studies
.
Psychother Psychosom
.
2015
;
84
(
5
):
265
72
.
[PubMed]
0033-3190
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.